Global Chlorpheniramine Maleate Market Forecast
- Chlorpheniramine maleate market size likely to rise up from US$0.5 Bn in 2022 to US$0.74 Bn by the end of 2030
- Market revenue poised to witness a CAGR of 5.5% during 2023 - 2030
Quick Report Digest
- The global chlorpheniramine maleate market's main development engine is the increase in disposable income. An antihistamine called chlorpheniramine is used to treat the signs and symptoms of allergic diseases such allergic rhinitis (hay fever). It is ingested orally.
- The market is expected to grow as a result of rising air pollution in developing nations like India, China, Brazil, and Mexico, rising consumer awareness of the value of treating allergic disorders, and rising healthcare spending.
- Chlorpheniramine maleate's potential adverse effects, including sleepiness, dizziness, dry mouth, blurred vision, and a growing preference for other treatments, are a hindrance to the industry's expansion.
- Due to an increase in allergies and the accessibility of chlorpheniramine maleate tablets, the tablets category, which held the greatest market share in 2022, is projected to grow at the quickest rate during the forecast period.
- The allergy ctegory held the largest market share in 2022 and is anticipated to grow at the fastest rate in the forecast period due to the rise in the prevalence of allergic disorders and the global expansion of the pharmaceutical industry, which produces formulations based on chlorpheniramine maleate to treat allergic disorders.
- Since hospital pharmacies dispense chlorpheniramine maleate in a variety of forms, including capsules, tablets, or liquid formulations, they are expected to continue to lead during the forecast period. In 2022, this sector experienced the highest growth.
- Due to improvements in healthcare infrastructure, easy access to healthcare services, such as OTC medications for allergic conditions, and an increase in the prevalence of allergic conditions in this region, North America held the majority share in 2022 and is projected to maintain its dominance in the forecast period.
- During the projection of the chlorpheniramine maleate market, Asia-Pacific is anticipated to grow at the fastest rate. A rise in the need for antihistaminics, a rise in the number of elderly people, and an increase in air pollution in developing nations like India, China, Japan, and South Korea all contribute to the market's expansion.
A Look Back and a Look Forward - Comparative Analysis
The population's growing awareness of allergies, the rise in demand for antihistamines, and the surge in pharmaceutical companies' investments in R&D activities for the creation of more potent antihistaminic drugs are the main factors driving the growth of the chlorpheniramine maleate market share.
Throughout the historical period of 2018-2022, the market had staggered growth. Over the years, the market for chlorpheniramine maleate has grown steadily, propelled by a number of important factors. There are more people seeking treatment for allergy symptoms as a result of environmental changes, increased pollution, and exposure to allergens. In addition, the ageing population, which is more vulnerable to allergies and their symptoms, is anticipated to fuel market growth.
The creation of new chlorpheniramine maleate formulations, such as extended-release tablets or liquid formulations, which offer improved convenience, efficacy, and patient compliance, has been made possible by advancements in pharmaceutical technology and drug delivery systems. These formulations are anticipated to create new opportunities for the market's expansion over the course of the forecast period. On the other hand, a spike in R&D efforts to provide novel medicines with fewer side effects and improved efficacy is anticipated to offer profitable chances for the market's expansion throughout the projection period.
Key Growth Determinants
- Rising Prevalence of Allergic Illnesses
The rising prevalence of allergic illnesses worldwide is a major driver of the chlorpheniramine maleate market. Asthma and allergy illness cases are rising globally, especially in low- and middle-income nations.
Between 10% and 30% of people worldwide suffer from allergic rhinitis. Among them, 400 million people have rhinitis, 200–250 million people have food allergies, one-tenth of the population has medication allergies, and 300 million people have asthma.
Moreover, antihistamines are drugs or other substances that limit the physiological effects of histamine and are used only to treat allergies. Antihistamines could include chlorpheniramine maleate.
- Broadening Application Range of Chlorphenamine
Chlorpheniramine maleate is a type of first-generation antihistamine that is commonly used to manage the symptoms of cold, and allergic rhinitis. The substance chlorpheniramine maleate seems to be a tasteless, white, crystalline solid or powder.
Hay fever, rhinitis, urticaria, and asthma symptoms can all be treated with chlorphenamine. An histamine-H1 receptor antagonist called chlorpheniramine is used to treat upper respiratory allergy symptoms. It has also been applied to veterinary purposes.
One of the most often used antihistamines, it normally causes less sleepiness and sedation than promethazine. The chlorpheniramine maleate market is thus expected to rise due to the increased use of chlorphenamine throughout the forecast period.
- Rapid Developments in Medication Devlivery Methods
The ease and efficiency of giving chlorpheniramine maleate have substantially increased because of the ongoing developments in medication delivery methods like transdermal patches, and nasal sprays.
The market is growing as a result of these technological advancements, which improve patient compliance. For instance, by using polymers that have been molecularly imprinted with chlorpheniramine maleate, new chlorpheniramine maleate (CPM) selective electrochemical membranes have been created.
In addition, the creation of novel products, new formulations, or combination therapy can be facilitated by funding research and development projects. To meet the changing needs of patients and healthcare professionals, this R&D emphasis can further improve the efficacy and safety profiles of chlorpheniramine maleate.
Major Growth Barriers
- Potential Side Effects
With rare occurrences of significant jaundice and aplastic anemia, chlorpheniramine's side effects include tiredness or atypical drowsiness, blurred or double vision, dry mouth, or xerostomia. It is not advised to be applied to people who have a known allergy to chlorpheniramine.
Application in children under the age of two is not advised. These problems are impeding the market's expansion for chlorpheniramine maleate.
- Availability of Substitute Drugs
The market for chlorpheniramine maleate is seriously threatened by the existence of substitute drugs. Patients & healthcare professionals alike are becoming more and more accustomed to using newer antihistamines with enhanced efficacy and fewer side effects, including loratadine or cetirizine. Chlorpheniramine maleate may lose market share as a result of the availability of these powerful substitutes.
Key Trends and Opportunities to Look at
- Increasing Scope Across Developing Economies
The market for chlorpheniramine maleate has a lot of room to grow in developing, and fast-developing markets. There is a growing need for easily available and reasonably priced drugs to treat allergies and respiratory disorders as these nations' economies rise and their healthcare infrastructure improves.
- Rising Focus on Respiratory Health in Recent Years
There is now more focus on respiratory health due to factors including pollution, urbanisation, and lifestyle changes. As a result of this increased awareness, respiratory diseases are more readily recognised, which increases the need for medications like chlorpheniramine maleate.
- Collaborative Activities
Chlorpheniramine maleate can be developed and sold through combined research, development, and commercialisation projects with pharmaceutical firms, healthcare providers, and academic institutions. These collaborations promote knowledge sharing, a broader market reach, and more accessibility to the treatment for patients all around the world.
How Does the Regulatory Scenario Shape this Industry?
The chlorpheniramine maleate market is primarily shaped by the regulatory environment, which has an effect on factors including production, quality, availability, and market entry.
Chlorpheniramine maleate is subject to strict quality and safety requirements set by regulatory organisations like the European Medicines Agency (EMA) in Europe, and the US FDA. Before a product is marketed to healthcare professionals and consumers, regulatory organisations must approve it.
Furthermore, the marketing and use of chlorpheniramine maleate are also influenced by regulatory organisations. They offer recommendations for product labelling that cover doses, indications, contraindications, and possible adverse reactions. Pharmaceutical businesses must follow these rules strictly.
Fairfield’s Ranking Board
Top Segments
- Tablets Continue to See Preference over Syrups
The tablets segment dominated the market in 2022. Tablets containing chlorpheniramine maleate are used orally to treat allergy symptoms. They provide comfort and precise dosing.
The market for chlorpheniramine maleate tablets has seen a trend of formulation improvements, including varieties that release slowly for more time-consuming relief and products that include other active ingredients to offer comprehensive allergy control.
During the anticipated time, the syrups industry is predicted to rise significantly due to the widespread availability of syrups containing the OTC chemical chlorpheniramine maleate and the rapid improvement of pharmaceutical technology and drug delivery technologies.
To increase patient compliance, there has been a trend of formulation upgrades and flavor upgrades in the chlorpheniramine maleate syrup industry.
- Allergy Management Largest Application Area
In 2022, the allergy category dominated the market, and it is predicted to grow significantly over the course of the forecast period. When used to treat allergies, chlorpheniramine maleate relieves symptoms like runny nose, itching, and sneezing.
Due to the increased prevalence of allergies and the need for efficient symptom relief, the market for chlorpheniramine maleate in allergy treatment has consistently grown.
Furthermore, the common cold category is expected to expand significantly. The common cold's associated runny nose and nasal congestion are occasionally treated with chlorpheniramine maleate. However, as more modern antihistamines and decongestants become more widely used on the market, their use for this purpose has been declining.
- Hospital Pharmacies Category Extends the Largest Revenue Contribution
The hospital pharmacies category held the majority of the market share. Hospital pharmacies are medical establishments that provide medication to both inpatient and outpatient settings. Hospital pharmacies are essential in the market for chlorpheniramine maleate because they provide the drug to medical experts so they can treat allergy symptoms in hospital settings.
During the forecasted years, the retail pharmacies is expected to be the fastest-growing category. These pharmacies offer both over-the-counter and prescription pharmaceuticals to the general public.
Retail pharmacies are essential in the market for making the drug available to customers for self-management of allergy symptoms. Retail pharmacies are increasingly offering full allergy management services, such as patient counseling, education, and individualised treatment recommendations.
Regional Frontrunners
North America Provides the Largest Playing Ground to Manufacturers
The biggest market share for chlorpheniramine maleate is expected to be across the North American market, characterised by an increasing concentration on individualised treatment, and accurate allergy management. To customise treatment approaches, the trend involves integrating cutting-edge diagnostic equipment and genetic testing.
The prevalence of allergic responses in the area is on the rise, which has led to a greater use of chlorpheniramine and contributed to the growth of this region. The chlorpheniramine maleate market is expanding rapidly in the North American region thanks to the presence of important companies like Cardinal Health, Inc. and the enormous patient pool seeking treatment.
Growing Prevalence of Allergies Instrumental in Rapid Market Build-up in Asia Pacific
The market for chlorpheniramine maleate is expanding at the fastest rate in Asia Pacific, which presents a significant opportunity for the industry because allergic reactions are becoming more prevalent in the area and chlorpheniramine is being used more frequently.
A faster pace of urbanisation has increased environmental pollution in the area, which has led to a rise in the number of allergy cases that necessitate the use of chlorpheniramine. These are other variables that have contributed to the expansion.
Furthermore, the growth of the chlorpheniramine maleate market in the Asia Pacific region is fueled by the presence of large patient pools that require treatment with chlorpheniramine in nations like India, where there is a high population.
Fairfield’s Competitive Landscape Analysis
Several large companies are striving for market dominance in the fiercely competitive chlorpheniramine maleate market. Pharmaceutical firms, producers of generic medications, and contract manufacturing businesses are some of these participants.
GlaxoSmithKline plc, Zydus Lifesciences Limited, and Novalab Healthcare Pvt. Ltd. are a few of the market's top businesses. To stay competitive, these businesses prioritise product innovation, strategic alliances, and regional development.
Who are the Leaders in Global Chlorpheniramine Maleate Space?
- Viatris Inc.
- Alkem Laboratories Ltd.
- Merck & Co., Inc.
- Johnson & Johnson
- Capellon Pharmaceuticals
- GlaxoSmithKline plc
- Zydus Lifesciences Limited
- Novalab Healthcare Pvt. Ltd.
- Sun Pharmaceutical Industries Limited
- Bayer AG
- Cardinal Health, Inc.
- AstraZeneca PLC
- BOC Sciences
- Mylan N.V.
- UCB, Inc.
Recent Company Developments
New Product Launches
- October 2021: The first authorised interchangeable biologic in the US has been approved by the Food and Drug Administration (FDA), and Cardinal Health has developed an interactive tool that offers crucial assistance to chemists. The long-acting insulin Semglee (insulin glargine-yfgn), which is now suggested as a biosimilar for one of the most widely used and pricey biologic medicines on the market right now - insulin, received FDA approval.
- September 2021: Chericof 12, a brand-new cough syrup, was introduced by Sun Pharmaceutical Industries Ltd. in India. The introduction of Chericof 12 will assist the business in establishing a strong presence in the chlorpheniramine maleate market.
- April 2021: To ease the burdens associated with medication non-compliance, Cardinal Health created OutcomesTM, a digital ecosystem connecting pharmacists, payers, and pharmaceutical companies. Through its ConnectTM platform, outcomes transfer digital health solutions are provided for tailored drug therapy delivery, digital patient interaction, and telepharmacy.
Distribution Agreement
- November 2021: WaveMarkTM Supply Management, and Workflow Solutions, which Cardinal Health announced, are now available for installation in clinical laboratories all over the US. 70% of medical decisions are based on the results of a laboratory test, making the role that clinical laboratories play in ensuring continuity of care vital. However, even before the pandemic, the clinical lab workforce was limited because of a combination of a retiring workforce inside the lab and an ageing population that increased testing demand.
Mergers & Acquisitions
- October 2020: Momenta Pharmaceuticals, Inc., a business that finds and creates innovative treatments for immune-mediated disorders, has been acquired by Johnson & Johnson in an all-cash deal valued at about US$6.5 Bn.
An Expert’s Eye
Market Demand and Future Growth
The market's expansion is related to the rise in allergy conditions as a result of the deteriorating environmental circumstances, such as increased air pollution. Additionally, the industry is expanding due to the increase of patients seeking therapy.
In addition, the coronavirus pandemic has prompted people to purchase drugs to prevent common cold symptoms like runny nose, and itchy eyes. The market for chlorpheniramine maleate is then predicted to rise as a result.
Supply Side of the Market
According to our analysis, due to their substantial pharmaceutical production capacities, China, and India were among the top suppliers of chlorpheniramine maleate. This drug is produced and sold all over the world with major assistance from the pharmaceutical industry.
Chlorpheniramine maleate is frequently supplied in large part by businesses located in nations with substantial pharmaceutical production capacities, such China, and India.
In contrast, the US dominates the chlorpheniramine maleate market in terms of consumption. This is brought on by the increased prevalence of allergies, the rising demand for OTC medications, and the rising disposable incomes in the area.
Global Chlorpheniramine Maleate Market is Segmented as Below:
By Dosage Form
- Tablets
- Syrup
- Eye Drops
By Application
- Allergy
- Hay Fever (Allergic Rhinitis)
- Common Cold
- Watery Eyes
- Itchy Throat/Skin
- Anaphylactic Shock
- Urticaria
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Geographic Coverage:
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Turkey
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Egypt
- Nigeria
- Rest of Middle East & Africa
1. Executive Summary
1.1. Global Chlorpheniramine Maleate Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Chlorpheniramine Maleate Market Outlook, 2018 - 2030
3.1. Global Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Allergy
3.1.1.2. Hay Fever (Allergic Rhinitis)
3.1.1.3. Common Cold
3.1.1.4. Watery Eyes
3.1.1.5. Itchy Throat/Skin
3.1.1.6. Anaphylactic Shock
3.1.1.7. Urticaria
3.2. Global Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Tablets
3.2.1.2. Syrup
3.2.1.3. Eye Drops
3.3. Global Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Hospital Pharmacies
3.3.1.2. Retail Pharmacies
3.3.1.3. Online Pharmacies
3.4. Global Chlorpheniramine Maleate Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Chlorpheniramine Maleate Market Outlook, 2018 - 2030
4.1. North America Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Allergy
4.1.1.2. Hay Fever (Allergic Rhinitis)
4.1.1.3. Common Cold
4.1.1.4. Watery Eyes
4.1.1.5. Itchy Throat/Skin
4.1.1.6. Anaphylactic Shock
4.1.1.7. Urticaria
4.2. North America Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Tablets
4.2.1.2. Syrup
4.2.1.3. Eye Drops
4.3. North America Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Hospital Pharmacies
4.3.1.2. Retail Pharmacies
4.3.1.3. Online Pharmacies
4.3.2. Market Attractiveness Analysis
4.4. North America Chlorpheniramine Maleate Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. U.S. Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
4.4.1.2. U.S. Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
4.4.1.3. U.S. Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
4.4.1.4. Canada Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
4.4.1.5. Canada Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
4.4.1.6. Canada Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Chlorpheniramine Maleate Market Outlook, 2018 - 2030
5.1. Europe Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Allergy
5.1.1.2. Hay Fever (Allergic Rhinitis)
5.1.1.3. Common Cold
5.1.1.4. Watery Eyes
5.1.1.5. Itchy Throat/Skin
5.1.1.6. Anaphylactic Shock
5.1.1.7. Urticaria
5.2. Europe Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Tablets
5.2.1.2. Syrup
5.2.1.3. Eye Drops
5.3. Europe Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Hospital Pharmacies
5.3.1.2. Retail Pharmacies
5.3.1.3. Online Pharmacies
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Chlorpheniramine Maleate Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Germany Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.2. Germany Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.3. Germany Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.4. U.K. Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.5. U.K. Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.6. U.K. Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.7. France Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.8. France Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.9. France Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.10. Italy Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.11. Italy Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.12. Italy Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.13. Turkey Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.14. Turkey Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.15. Turkey Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.16. Russia Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.17. Russia Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.18. Russia Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.1.19. Rest of Europe Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
5.4.1.20. Rest of Europe Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
5.4.1.21. Rest of Europe Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Chlorpheniramine Maleate Market Outlook, 2018 - 2030
6.1. Asia Pacific Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Allergy
6.1.1.2. Hay Fever (Allergic Rhinitis)
6.1.1.3. Common Cold
6.1.1.4. Watery Eyes
6.1.1.5. Itchy Throat/Skin
6.1.1.6. Anaphylactic Shock
6.1.1.7. Urticaria
6.2. Asia Pacific Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Tablets
6.2.1.2. Syrup
6.2.1.3. Eye Drops
6.3. Asia Pacific Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Hospital Pharmacies
6.3.1.2. Retail Pharmacies
6.3.1.3. Online Pharmacies
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Chlorpheniramine Maleate Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. China Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.2. China Chlorpheniramine Maleate Market, by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.3. China Chlorpheniramine Maleate Market, by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.1.4. Japan Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.5. Japan Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.6. Japan Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.1.7. South Korea Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.8. South Korea Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.9. South Korea Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.1.10. India Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.11. India Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.12. India Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.1.13. Southeast Asia Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.14. Southeast Asia Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.15. Southeast Asia Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.1.16. Rest of Asia Pacific Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
6.4.1.17. Rest of Asia Pacific Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
6.4.1.18. Rest of Asia Pacific Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Chlorpheniramine Maleate Market Outlook, 2018 - 2030
7.1. Latin America Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Allergy
7.1.1.2. Hay Fever (Allergic Rhinitis)
7.1.1.3. Common Cold
7.1.1.4. Watery Eyes
7.1.1.5. Itchy Throat/Skin
7.1.1.6. Anaphylactic Shock
7.1.1.7. Urticaria
7.2. Latin America Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030 7.2.1. Key Highlights 7.2.1.1. Tablets
7.2.1.2. Syrup
7.2.1.3. Eye Drops
7.3. Latin America Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030 7.3.1. Key Highlights
7.3.1.1. Hospital Pharmacies
7.3.1.2. Retail Pharmacies
7.3.1.3. Online Pharmacies
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Chlorpheniramine Maleate Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Brazil Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
7.4.1.2. Brazil Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
7.4.1.3. Brazil Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
7.4.1.4. Mexico Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
7.4.1.5. Mexico Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
7.4.1.6. Mexico Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
7.4.1.7. Argentina Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
7.4.1.8. Argentina Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
7.4.1.9. Argentina Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
7.4.1.10. Rest of Latin America Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
7.4.1.11. Rest of Latin America Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
7.4.1.12. Rest of Latin America Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Chlorpheniramine Maleate Market Outlook, 2018 - 2030
8.1. Middle East & Africa Chlorpheniramine Maleate Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Allergy
8.1.1.2. Hay Fever (Allergic Rhinitis)
8.1.1.3. Common Cold
8.1.1.4. Watery Eyes
8.1.1.5. Itchy Throat/Skin
8.1.1.6. Anaphylactic Shock
8.1.1.7. Urticaria
8.2. Middle East & Africa Chlorpheniramine Maleate Market Outlook, by Dosage Form, Value (US$ Bn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Tablets
8.2.1.2. Syrup
8.2.1.3. Eye Drops
8.3. Middle East & Africa Chlorpheniramine Maleate Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Hospital Pharmacies
8.3.1.2. Retail Pharmacies
8.3.1.3. Online Pharmacies
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Chlorpheniramine Maleate Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. GCC Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
8.4.1.2. GCC Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
8.4.1.3. GCC Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.4.1.4. South Africa Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
8.4.1.5. South Africa Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
8.4.1.6. South Africa Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.4.1.7. Egypt Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
8.4.1.8. Egypt Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
8.4.1.9. Egypt Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.4.1.10. Nigeria Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
8.4.1.11. Nigeria Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
8.4.1.12. Nigeria Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.4.1.13. Rest of Middle East & Africa Chlorpheniramine Maleate Market by Application, Value (US$ Bn), 2018 - 2030
8.4.1.14. Rest of Middle East & Africa Chlorpheniramine Maleate Market by Dosage Form, Value (US$ Bn), 2018 - 2030
8.4.1.15. Rest of Middle East & Africa Chlorpheniramine Maleate Market by Distribution Channel, Value (US$ Bn), 2018 - 2030
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs Application Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Sun Pharmaceutical Industries Limited
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Novalab Healthcare Pvt. Ltd
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Zydus Lifesciences Limited
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. GlaxoSmithKline plc
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Capellon Pharmaceuticals
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Johnson & Johnson
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Merck & Co., Inc.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Alkem Laboratories Ltd.
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Viatris Inc.
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Bayer AG
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Cardinal Health, Inc.
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. AstraZenca PLC
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. BOC Sciences
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Mylan N.V.
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
9.4.15. UCB, Inc.
9.4.15.1. Company Overview
9.4.15.2. Product Portfolio
9.4.15.3. Financial Overview
9.4.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations
|
BASE YEAR |
HISTORICAL DATA |
FORECAST PERIOD |
UNITS |
|||
 |
2022 |
 |
2018 - 2022 |
 |
2023 - 2030 |
Value: US$ Million |
|
REPORT FEATURES |
DETAILS |
|
Dosage Form Coverage |
|
|
Application Coverage |
|
|
Distribution Channel Coverage |
|
|
Geographical Coverage |
|
|
Leading Companies |
|
|
Report Highlights |
Key Market Indicators, Macro-micro economic impact analysis,Technological Roadmap, Key Trends, Driver, Restraints, and Future Opportunities & Revenue Pockets, Porter’s 5 Forces Analysis, Historical Trend (2019-2021), Market Estimates and Forecast, Market Dynamics, Industry Trends, Competition Landscape, Category, Region, Country-wise Trends & Analysis, COVID-19 Impact Analysis (Demand and Supply Chain) |
Quality assured
